Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. New England Cancer Specialists - Topsham

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Google.

Our Topsham location provides expert cancer care for mid-coast Maine, offering medical oncology, chemotherapy, immunotherapy, and access to clinical trials. Patients benefit from a collaborative care team, including nurse navigators, social workers, and financial counselors. Personalized care plans, survivorship support, and regular follow-ups ensure that patients receive the highest level of care throughout their cancer journey. As an affiliate member of the Dana-Farber Cancer Institute, NECS connects patients to the latest advances in cancer treatment and research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Cancer treatment center

Business Subcategory

Source: Google. Cancer treatment center
Source: Google. Doctor
Source: Google. Hematologist
Source: Google. Internist
Source: Google. Oncologist
Source: Trial-derived.
15Total Trials
Source: Trial-derived.
4Recruiting Trials
Source: Trial-derived.
12Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
100Unique Conditions
Source: Trial-derived.
20Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Stage IB Lung Non-Small Cell Carcinoma AJCC v7 (3)Source: Trial-derived. Stage IIIA Lung Non-Small Cell Cancer AJCC v7 (3)Source: Trial-derived. Stage II Lung Non-Small Cell Cancer AJCC v7 (3)Source: Trial-derived. Multiple Myeloma (2)Source: Trial-derived. Advanced Lymphoma (1)Source: Trial-derived. Advanced Malignant Solid Neoplasm (1)Source: Trial-derived. Advanced Solid Tumors (1)Source: Trial-derived. Anatomic Stage I Breast Cancer AJCC v8 (1)

Sponsors

Source: Trial-derived. National Cancer Institute (NCI) (8)Source: Trial-derived. Pfizer (4)Source: Trial-derived. Alliance Foundation Trials, LLC. (1)Source: Trial-derived. American Society of Clinical Oncology (1)Source: Trial-derived. Astellas Pharma Global Development, Inc. (1)Source: Trial-derived. AstraZeneca (1)Source: Trial-derived. Bayer (1)Source: Trial-derived. Boehringer Ingelheim (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Echocardiography
Source: AI-inferred. MRI
Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Biobanking
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Circulating tumour DNA testing
Source: AI-inferred. Pharmacokinetic bioanalysis

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. BRAF V600E mutation testing
Source: AI-inferred. Dynamic susceptibility contrast perfusion MRI